zvra20230316_defa14a.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 


SCHEDULE 14A

(Rule 14a-101)

INFORMATION REQUIRED IN PROXY STATEMENT

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

(Amendment No.    )


Filed by the Registrant  ☒                             Filed by a Party other than the Registrant  ☐

 

Check the appropriate box:

 

Preliminary Proxy Statement

   

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

   

Definitive Proxy Statement

   

Definitive Additional Materials

   

Soliciting Material under §240.14a-12

 

Zevra Therapeutics, Inc.

(Name of Registrant as Specified in its Charter)

 

(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)

 

Payment of Filing Fee (Check all boxes that apply):

 

No fee required

   

Fee paid previously with preliminary materials

   

Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

 



 

 

https://cdn.kscope.io/52f2c9eb01cecfb185920857005badfc-a01.jpg
 

https://cdn.kscope.io/52f2c9eb01cecfb185920857005badfc-a02.jpg
 

https://cdn.kscope.io/52f2c9eb01cecfb185920857005badfc-a03.jpg
 

https://cdn.kscope.io/52f2c9eb01cecfb185920857005badfc-a04.jpg
 

https://cdn.kscope.io/52f2c9eb01cecfb185920857005badfc-a05.jpg
 

https://cdn.kscope.io/52f2c9eb01cecfb185920857005badfc-a06.jpg